CN102552456B - Medicament for treating anxiety neurosis - Google Patents
Medicament for treating anxiety neurosis Download PDFInfo
- Publication number
- CN102552456B CN102552456B CN 201210008026 CN201210008026A CN102552456B CN 102552456 B CN102552456 B CN 102552456B CN 201210008026 CN201210008026 CN 201210008026 CN 201210008026 A CN201210008026 A CN 201210008026A CN 102552456 B CN102552456 B CN 102552456B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- anxiety neurosis
- treatment
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating an anxiety neurosis, which is prepared from the following raw medicine in parts by weight: 3-10 parts of shizandra berry, 10-20 parts of polygala tenuifolia, 10-30 parts of Astragalus root, 10-30 parts of spina date seed, 5-15 parts of cassia twig, 5-10 parts of honeysuckle, 5-15 parts of bighead atractylodes rhizome, 10-20 parts of acanthopanax root, 10-20 parts of Albizia julibrissin and 10-20 parts of glaucousback threewingnut root-bark. The medicament for treating the anxiety neurosis, disclosed by the invention, utilizes natural medicines and has the advantages of rapid effect, obvious therapeutic effect, good tolerance, low cost, and no toxic side effects.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament for the treatment of anxiety neurosis.
Background technology
Anxiety neurosis claims anxiety neurosis again, it be with persistence nervous worry, frightened or ictal be the dysthymic disorder of feature in terror, with behavior characteristicss such as autonomic nervous system symptom and motion uneasinesses.The anxiety that anxiety patient shows or fear often do not have flesh and blood or are not inconsistent with real situation.Doctor trained in Western medicine is mainly used pharmaceutical intervention to the treatment of primary disease at present, but existing medicine exist dependency, onset slowly, problems such as untoward reaction.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of anxiety neurosis.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of anxiety neurosis, it is to be made by weight by following bulk drugs: Fructus Schisandrae Chinensis 3-10 part, Radix Polygalae 10-20 part, Radix Astragali 10-30 part, Semen Ziziphi Spinosae 10-30 part, Ramulus Cinnamomi 5-15 part, Flos Lonicerae 5-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part, Flos Albiziae 10-20 part and Cortex tripterygii hypoglauci radicis 10-20 part.
Preferably, it is to be made by weight by following bulk drugs: 15 parts of 5 parts of Fructus Schisandrae Chinensis, 15 parts of Radix Polygalaes, 20 parts of the Radixs Astragali, 20 parts of Semen Ziziphi Spinosaes, 10 parts of Ramulus Cinnamomi, 5 parts of Flos Loniceraes, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 15 parts of Flos Albiziaes and Cortex tripterygii hypoglauci radiciss.
Preferably, described medicament is tablet, dispersible tablet, disintegrating tablet, powder or granule.
When the medicament of preparation treatment anxiety neurosis of the present invention, can use pharmaceutically acceptable carrier to be prepared together.Described pharmaceutically acceptable carrier comprises disintegrating agent, excipient, binding agent, antiseptic, binding agent, lubricant etc.
Use natural drug in the medicament for the treatment of anxiety neurosis of the present invention, find through clinical practice, have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Take by weighing Fructus Schisandrae Chinensis 50 grams, Radix Polygalae 150 grams, the Radix Astragali 200 grams, Semen Ziziphi Spinosae 200 grams, Ramulus Cinnamomi 100 grams, Flos Lonicerae 50 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Radix Et Caulis Acanthopanacis Senticosi 150 grams, Flos Albiziae 150 grams and Cortex tripterygii hypoglauci radicis 150 grams, pulverize, cross 100 mesh sieves, add glucide 300 grams then, mixing is packed in 100 bags namely.
Experimental example
This group of clinical data case 50 examples, male 25 examples wherein, women 25 examples; 22～48 years old age, average 33 years old.Diagnostic criteria with reference to the diagnostic criteria of CCMD-3 anxiety neurosis (psychiatric department branch of Chinese Medical Association. Chinese mental disorder classification and diagnostic criteria [M] the 3rd edition. Jinan: the 2001:103 of Shandong science tech publishing house), disease is seen depressed and discontented disgruntled, depression of liver-QI, sorrow is pondered over, dysfunction of the spleen in transportation.
Use the powder that makes among the embodiment 1 to treat, wherein one day 3 times, each one bag, treating two months is a course for the treatment of.
Criterion of therapeutical effect is evaluated by the traditional Chinese medical science disease diagnosis criterion of therapeutical effect of Chinese combination of Chinese and Western medicine mental sickness Professional Committee of association revision in 1991.Recovery from illness: transference cure, emotion is ended normal; Take a turn for the better: sx, emotion is basicly stable; Invalid: symptom, emotion all end are obviously improved.
Through the observation of a course for the treatment of is arranged, finding to have 50 patient treatment effects all is recovery from illness, and does not observe tangible untoward reaction during whole treatment.
After treating a course for the treatment of, all the patient is followed up a case by regular visits to weekly, continue half a year, find the sign of recurrence.
Claims (2)
1. medicament for the treatment of anxiety neurosis, it is characterized in that it is to be made by weight by following bulk drugs: 15 parts of 5 parts of Fructus Schisandrae Chinensis, 15 parts of Radix Polygalaes, 20 parts of the Radixs Astragali, 20 parts of Semen Ziziphi Spinosaes, 10 parts of Ramulus Cinnamomi, 5 parts of Flos Loniceraes, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Radix Et Caulis Acanthopanacis Senticosis, 15 parts of Flos Albiziaes and Cortex tripterygii hypoglauci radiciss.
2. the medicament for the treatment of anxiety neurosis according to claim 1 is characterized in that, described medicament is tablet, powder or granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210008026 CN102552456B (en) | 2012-01-12 | 2012-01-12 | Medicament for treating anxiety neurosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210008026 CN102552456B (en) | 2012-01-12 | 2012-01-12 | Medicament for treating anxiety neurosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552456A CN102552456A (en) | 2012-07-11 |
| CN102552456B true CN102552456B (en) | 2013-08-07 |
Family
ID=46399911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210008026 Expired - Fee Related CN102552456B (en) | 2012-01-12 | 2012-01-12 | Medicament for treating anxiety neurosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552456B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807554A (en) * | 1997-04-11 | 1998-09-15 | Yng-Wong; Quing Non | Herbal formulations with nacre |
| CN1709475A (en) * | 2005-06-22 | 2005-12-21 | 贵州同济堂制药股份有限公司 | Chinese medicine formulation for treating extensive anxiety, and its preparing method |
| US20060147569A1 (en) * | 2005-01-03 | 2006-07-06 | Hsiang-Fu Kung | Anti-depression formulations |
| WO2010076913A1 (en) * | 2009-01-05 | 2010-07-08 | Health-Love Co., Ltd | Pomegranate extracts from pomegranate flesh, and composition for improving postmenopausal syndrome comprising effective amount of the same |
| CN101773651A (en) * | 2010-04-19 | 2010-07-14 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composition for treating headache and preparation method thereof |
| WO2011118891A1 (en) * | 2010-03-26 | 2011-09-29 | 성균관대학교 산학협력단 | Pharmaceutical composition including sulfuretin or pharmaceutically acceptable salt thereof for prevention and treatment of nervous system disorder |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005060357A (en) * | 2003-08-12 | 2005-03-10 | ▲張▼ ▲書▼廷 | Health food for promoting sleep and tranquirizing by using plant as raw material and method for producing the same |
-
2012
- 2012-01-12 CN CN 201210008026 patent/CN102552456B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807554A (en) * | 1997-04-11 | 1998-09-15 | Yng-Wong; Quing Non | Herbal formulations with nacre |
| US20060147569A1 (en) * | 2005-01-03 | 2006-07-06 | Hsiang-Fu Kung | Anti-depression formulations |
| CN1709475A (en) * | 2005-06-22 | 2005-12-21 | 贵州同济堂制药股份有限公司 | Chinese medicine formulation for treating extensive anxiety, and its preparing method |
| WO2010076913A1 (en) * | 2009-01-05 | 2010-07-08 | Health-Love Co., Ltd | Pomegranate extracts from pomegranate flesh, and composition for improving postmenopausal syndrome comprising effective amount of the same |
| WO2011118891A1 (en) * | 2010-03-26 | 2011-09-29 | 성균관대학교 산학협력단 | Pharmaceutical composition including sulfuretin or pharmaceutically acceptable salt thereof for prevention and treatment of nervous system disorder |
| CN101773651A (en) * | 2010-04-19 | 2010-07-14 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composition for treating headache and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| JP特开200560357A 2005.03.10 |
| 中西医结合治疗神经衰弱70例;张赐安;《新中医》;20020731;第34卷(第7期);第61-62页，第61页右栏倒数第1-3行，第62页左栏第1行 * |
| 张赐安.中西医结合治疗神经衰弱70例.《新中医》.2002,第34卷(第7期),第61-62页，第61页右栏倒数第1-3行，第62页左栏第1行. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552456A (en) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101530579B (en) | A pharmaceutical composition for soothing the nerves | |
| CN103272127B (en) | Preparation for treating epilepsy | |
| CN102657819B (en) | Drug combination for treating dysthymic disorder | |
| CN102552456B (en) | Medicament for treating anxiety neurosis | |
| CN102526645B (en) | Medicament for treating dysthymic disorder | |
| CN102258723B (en) | Traditional Chinese medicine composition for treating chronic hepatitis B | |
| CN102416147B (en) | Medicinal composition for treating mania of patients abstained from drugs | |
| CN102670952B (en) | Medicine for treating insomnia | |
| CN103142974A (en) | Medicament for treating anxiety disorder | |
| CN103495013B (en) | Medicament for treating anxiety disorder in psychiatric nursing | |
| CN102908507B (en) | Medicament for treating bone disease | |
| CN102600430A (en) | Medicine for curing femoral head necrosis | |
| CN102526373B (en) | Medicinal composition for treating infantile anorexia | |
| CN102657737B (en) | Medicament for treating acute gouty arthritis | |
| CN101816768B (en) | Chinese medicinal composition for treating somatoform disorder and preparation method thereof | |
| CN102552581B (en) | Medicament for treating insomnia | |
| CN102319320B (en) | Medicament for treating osteopathy | |
| CN103877475B (en) | Oral pharmaceutical preparation for treating mania | |
| CN103784742A (en) | Medicinal preparation for treating chronic lumbar strain | |
| CN102657775B (en) | Medicament composition for treating depression | |
| CN102671048B (en) | Medicament for treating chronic urinary tract infections | |
| CN104274774A (en) | Traditional Chinese medicine composition for treating qi-stagnation blood-stasis type endometriosis | |
| CN102961727B (en) | Traditional Chinese medicine composition for treating bone diseases in clinical nursing | |
| CN102488829B (en) | Medicine for treating bone disease | |
| CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG XINMIN Free format text: FORMER OWNER: LI ZUNQING Effective date: 20150107 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272051 JINING, SHANDONG PROVINCE TO: 226400 ZHENJIANG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150107 Address after: 226400 No. 34 Jianghai Road, Rudong Town, Jiangsu County Patentee after: Wang Xinmin Address before: 272051 Shandong province Jining city wear Zhuangji wearing No. 1 Shandong Road, Jining city mental hospital Patentee before: Li Zunqing |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130807 Termination date: 20190112 |